An Empirical Phase Diagram–High‐Throughput Screening Approach to the Characterization and Formulation of Biopharmaceuticals
暂无分享,去创建一个
C. Russell Middaugh | Sangeeta B. Joshi | S. Joshi | A. Bhambhani | Yuhong Zeng | Akhilesh Bhambhani | Yuhong Zeng | C. Middaugh | Akhilesh Bhambhani | C. Middaugh
[1] S. Venyaminov,et al. Determination of Protein Secondary Structure , 1996 .
[2] David R. Olsen,et al. The structure, stability, and complex behavior of recombinant human gelatins. , 2007, Journal of pharmaceutical sciences.
[3] C. R. Middaugh,et al. Stabilization of proteins by low molecular weight multi-ions. , 2002, Journal of pharmaceutical sciences.
[4] Vincent J. Sullivan,et al. Anthrax vaccine powder formulations for nasal mucosal delivery. , 2006, Journal of pharmaceutical sciences.
[5] S. Joshi,et al. Spectroscopic methods for the physical characterization and formulation of nonviral gene delivery systems. , 2008, Methods in molecular biology.
[6] L. Stryer,et al. The interaction of a naphthalene dye with apomyoglobin and apohemoglobin. A fluorescent probe of non-polar binding sites. , 1965, Journal of molecular biology.
[7] Aaron M. Smalter,et al. Stability of the Clostridium botulinum type A neurotoxin complex: an empirical phase diagram based approach. , 2007, Molecular pharmaceutics.
[8] S. Joshi,et al. Biophysical and stabilization studies of the Chlamydia trachomatis mouse pneumonitis major outer membrane protein. , 2009, Molecular Pharmaceutics.
[9] Haihong Fan,et al. Conformational lability of two molecular chaperones Hsc70 and gp96: effects of pH and temperature. , 2006, Archives of biochemistry and biophysics.
[10] Vassar Ps,et al. Fluorescent stains, with special reference to amyloid and connective tissues. , 1959 .
[11] Structural characterization of bovine granulocyte colony stimulating factor: effect of temperature and pH. , 2003, Journal of pharmaceutical sciences.
[12] L. Peek,et al. A rapid, three-step process for the preformulation of a recombinant ricin toxin A-chain vaccine. , 2007, Journal of pharmaceutical sciences.
[13] Jay R. Unruh,et al. Conformational flexibility, hydration and state parameter fluctuations of fibroblast growth factor-10: effects of ligand binding. , 2006, Biochemistry.
[14] T. Vedvick,et al. Conformational Stability and Disassembly of Norwalk Virus-like Particles , 2006, Journal of Biological Chemistry.
[15] J. Ralston,et al. Solution Behavior of IFN-β-1a: An Empirical Phase Diagram Based Approach , 2005 .
[16] P. S. Hefty,et al. Biophysical characterization of Chlamydia trachomatis CT584 supports its potential role as a type III secretion needle tip protein. , 2009, Biochemistry.
[17] S. Joshi,et al. Towards development of stable formulations of a live attenuated bacterial vaccine: A preformulation study facilitated by a biophysical approach , 2009, Human vaccines.
[18] M. Garcia-Alai,et al. The HPV16 E7 viral oncoprotein self-assembles into defined spherical oligomers. , 2004, Biochemistry.
[19] C Russell Middaugh,et al. Formulation design and high-throughput excipient selection based on structural integrity and conformational stability of dilute and highly concentrated IgG1 monoclonal antibody solutions. , 2012, Journal of pharmaceutical sciences.
[20] Maya S. Salnikova,et al. Preformulation studies of Clostridium difficile toxoids A and B. , 2008, Journal of pharmaceutical sciences.
[21] C. Russell Middaugh,et al. Ultraviolet absorption and circular dichroism spectroscopy of nonviral gene delivery complexes. , 2001, Methods in molecular medicine.
[22] P. R. Hof,et al. An improved thioflavine S method for staining neurofibrillary tangles and senile plaques in Alzheimer's disease , 1992, Experientia.
[23] Karthik Vishwanath,et al. Fluorescence Spectroscopy In Vivo , 2011 .
[24] H. Levine,et al. Thioflavine T interaction with synthetic Alzheimer's disease β‐amyloid peptides: Detection of amyloid aggregation in solution , 1993, Protein science : a publication of the Protein Society.
[25] S. Joshi,et al. Investigation of protein conformational stability employing a multimodal spectrometer. , 2011, Analytical chemistry.
[26] Haihong Fan,et al. Effects of solutes on empirical phase diagrams of human fibroblast growth factor 1. , 2007, Journal of pharmaceutical sciences.
[27] Maya S. Salnikova,et al. Physical characterization of clostridium difficile toxins and toxoids: effect of the formaldehyde crosslinking on thermal stability. , 2008, Journal of pharmaceutical sciences.
[28] V. Kickhoefer,et al. Structural stability of vault particles. , 2009, Journal of pharmaceutical sciences.
[29] C. Woodward,et al. Hydrogen exchange kinetics and internal motions in proteins and nucleic acids. , 1979, Annual review of biophysics and bioengineering.
[30] L. Peek,et al. A systematic approach to stabilizing EBA-175 RII-NG for use as a malaria vaccine. , 2006, Vaccine.
[31] C Russell Middaugh,et al. Physical stabilization of Norwalk virus-like particles. , 2008, Journal of pharmaceutical sciences.
[32] C. Russell Middaugh,et al. Stabilization of measles virus for vaccine formulation , 2008, Human vaccines.
[33] S. Joshi,et al. H1N1 influenza virus-like particles: physical degradation pathways and identification of stabilizers. , 2011, Journal of pharmaceutical sciences.
[34] W. Picking,et al. The response of type three secretion system needle proteins MxiHΔ5, BsaLΔ5, and PrgIΔ5 to temperature and pH , 2008, Proteins.
[35] J. Fric,et al. Studies on the conformation of protonated DNA , 1968, Biopolymers.
[36] S. Joshi,et al. Biophysical characterization and conformational stability of Ebola and Marburg virus-like particles. , 2011, Journal of pharmaceutical sciences.
[37] C. R. Middaugh,et al. Effects of pH and polyanions on the thermal stability of fibroblast growth factor 20. , 2007, Molecular pharmaceutics.
[38] J. Pettegrew,et al. Quantitative evaluation of congo red binding to amyloid-like proteins with a beta-pleated sheet conformation. , 1989, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[39] C R Middaugh,et al. Highly concentrated monoclonal antibody solutions: direct analysis of physical structure and thermal stability. , 2007, Journal of pharmaceutical sciences.
[40] E. Freire,et al. Differential scanning calorimetry. , 2008, Methods in cell biology.
[41] C Russell Middaugh,et al. Effect of pH and ionic strength on the physical stability of adenovirus type 5. , 2006, Journal of pharmaceutical sciences.
[42] K. Dill,et al. A statistical mechanical model for hydrogen exchange in globular proteins , 1995, Protein science : a publication of the Protein Society.
[43] N. Puri,et al. Spectrofluorimetric assessment of the surface hydrophobicity of proteins. , 1992, The Biochemical journal.
[44] S. Birket,et al. pH sensitivity of type III secretion system tip proteins , 2008, Proteins.
[45] S. Joshi,et al. Using spectroscopic and microscopic methods to probe the structural stability of human adenovirus type 4 , 2010, Human vaccines.
[46] H. Levine. Quantification of beta-sheet amyloid fibril structures with thioflavin T. , 1999, Methods in enzymology.
[47] V. Stella,et al. Stability of Drugs and Dosage Forms , 2000, Springer US.
[48] M. Eftink,et al. Dynamics of a protein matrix revealed by fluorescence quenching. , 1975, Proceedings of the National Academy of Sciences of the United States of America.
[49] C. Russell Middaugh,et al. Light-scattering techniques for characterization of synthetic gene therapy vectors. , 2001, Methods in molecular medicine.
[50] C. MacPhee,et al. Human apolipoprotein C-II forms twisted amyloid ribbons and closed loops. , 2000, Biochemistry.
[51] S. Joshi,et al. The interaction of heparin/polyanions with bovine, porcine, and human growth hormone. , 2008, Journal of pharmaceutical sciences.
[52] Steven J Shire,et al. Challenges in the development of high protein concentration formulations. , 2004, Journal of pharmaceutical sciences.
[53] Talia T Martin,et al. Thermal stability of adenovirus type 2 as a function of pH. , 2006, Journal of pharmaceutical sciences.
[54] D. Matulis,et al. 1-Anilino-8-naphthalene sulfonate anion-protein binding depends primarily on ion pair formation. , 1998, Biophysical journal.
[55] C. R. Middaugh,et al. Biophysical characterization of polymeric and liposomal gene delivery systems using empirical phase diagrams. , 2006, Journal of pharmaceutical sciences.
[56] S. Joshi,et al. Biophysical characterization of rotavirus serotypes G1, G3, and G4 , 2010, Human vaccines.
[57] Tim J Kamerzell,et al. Using empirical phase diagrams to understand the role of intramolecular dynamics in immunoglobulin G stability. , 2009, Journal of pharmaceutical sciences.
[58] Akihisa Nonoyama,et al. A biophysical characterization of the peptide drug pramlintide (AC137) using empirical phase diagrams. , 2008, Journal of pharmaceutical sciences.
[59] V. Bhakuni,et al. 8-anilino-1-naphthalene sulfonic acid (ANS) induces folding of acid unfolded cytochrome c to molten globule state as a result of electrostatic interactions. , 1999, Biochemistry.
[60] S. Ausar,et al. Analysis of the thermal and pH stability of human respiratory syncytial virus. , 2005, Molecular pharmaceutics.
[61] C Russell Middaugh,et al. Derivative absorbance spectroscopy and protein phase diagrams as tools for comprehensive protein characterization: a bGCSF case study. , 2003, Journal of pharmaceutical sciences.
[62] S. Ausar,et al. High-throughput screening of stabilizers for Respiratory Syncytial Virus: Identification of stabilizers and their effects on the conformational thermostability of viral particles , 2007, Human vaccines.
[63] T. Siahaan,et al. Evaluation of the physical stability of the EC5 domain of E-cadherin: effects of pH, temperature, ionic strength, and disulfide bonds. , 2009, Journal of pharmaceutical sciences.
[64] Susan Hershenson,et al. Practical approaches to protein formulation development. , 2002, Pharmaceutical biotechnology.